T1	Participants 98 149	333 seronegative African American female drug users
T2	Participants 399 411	Participants
T3	Participants 525 633	randomly assigned to one of two enhanced gender-specific and culturally specific HIV intervention conditions
T4	Participants 669 681	Participants
T5	Participants 1217 1222	Women
T6	Participants 990 995	women
T7	Participants 1317 1322	women
T8	Participants 1366 1393	motivation intervention arm
T9	Participants 1540 1563	effective interventions
T10	Participants 1611 1626	high-risk women
